Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 25, 2025

Analog Devices forecasts $3.1B Q1 revenue as industrial and communications lead FY26 growth

View original at seekingalpha.com
Analog Devices forecasts $3.1B Q1 revenue as industrial and communications lead FY26 growth Earnings Call Insights: Analog Devices (ADI) Q4 2025 MANAGEMENT VIEW * CEO Vincent Roche reported "continued growth in revenue and earnings per share, both of which finished above the midpoint of our outlook," noting that all en…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Aerospace and defense is expected to see double-digit growth in FY26 and the business has the capacity by the end of the decade to more than double

    80% confidence
  • Expectation is that in FY26, industrial and communications will lead the charge

    80% confidence
  • Revenue for fiscal 2025 came in at just over $11 billion, up 17% from fiscal 2024, with double-digit growth across all end markets

    80% confidence
  • Automotive has been the strongest market but near term the market has been more resilient than predicted, though some upside may have been tariff and policy related

    80% confidence
  • Lead times for most products are sub-13 weeks and visibility has not necessarily improved over the last 2 years

    80% confidence
  • Double-digit growth expected in aerospace and defense for FY2026, with business having capacity to more than double by end of the decade

    80% confidence
  • Maxim revenue synergies clearly accelerated in FY25 and are in the hundreds of millions against $1 billion target by 2027

    80% confidence
  • Auto has been ADI's strongest market and near term the market has been more resilient than predicted

    80% confidence
  • Q1 2026 revenue expected to be $3.1 billion, plus or minus $100 million, with operating margin at the midpoint of 43.5%

    80% confidence
  • There is risk in auto around tariff and some of the macro environment

    80% confidence
  • Wireless communications bottomed during the year with expectations for recovery

    80% confidence
  • Communications expected to be up 10% above seasonal

    80% confidence
  • Lead times are sub-13 weeks for most products and visibility has not necessarily improved over the last 2 years

    80% confidence
  • ADI generated record free cash flow of more than $4 billion in fiscal 2025

    80% confidence
  • Aerospace and defense expected to have double-digit growth in FY26 and business has the capacity by the end of the decade to more than double

    80% confidence
  • New Acoustics platform is enabling ADI to triple the value generated over legacy designs

    80% confidence
  • Data center business grew about 50% in FY2025 and ATE business grew at 40%

    80% confidence
  • Wireless communications bottomed during the year with expectations for recovery

    80% confidence
  • Data center business in FY25 grew about 50% and ATE business grew at 40% last year

    80% confidence
  • ADI is realizing stronger value capture as reflected in increase in average selling prices, particularly in new products where ASPs significantly exceed legacy offerings

    80% confidence
  • Individual end market margins versus average have not changed in any meaningful way

    80% confidence
  • Industrial expected to be up mid-single digits above seasonal

    80% confidence
  • Fiscal 2025 gross margin was 69.3% and operating margin was 41.9%

    80% confidence
  • Maxim revenue synergies clearly accelerated in FY25 and are in the hundreds of millions against $1 billion target by 2027

    80% confidence
  • Revenue for the year came in at just over $11 billion, up 17% from fiscal '24, with double-digit growth across all end markets

    80% confidence
  • Data center grew about 50% in fiscal 2025 and ATE business grew at 40%

    80% confidence
  • Maxim revenue synergies clearly accelerated in FY2025 and are in the hundreds of millions against $1 billion target by 2027

    80% confidence
  • ADI is realizing stronger value capture as reflected in the increase in average selling prices, particularly in new products where ASPs significantly exceed those of legacy offerings

    80% confidence
  • Expectation that in FY26, industrial and communications will lead the charge

    80% confidence
  • Maxim revenue synergies clearly accelerated in '25, and it's in the hundreds of millions against our $1 billion target by '27

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com